Alaunos Therapeutics, Inc.
TCRT
$2.08
$0.010.48%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.11M | -4.18M | -4.03M | -3.99M | -4.07M |
| Total Depreciation and Amortization | 15.00K | 7.00K | -1.00K | -1.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 900.00K | 827.00K | 665.00K | 444.00K | 331.00K |
| Change in Net Operating Assets | 66.00K | 473.00K | 452.00K | 704.00K | -87.00K |
| Cash from Operations | -3.13M | -2.87M | -2.91M | -2.85M | -3.83M |
| Capital Expenditure | -98.00K | -98.00K | -97.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -98.00K | -98.00K | -97.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.91M | 1.91M | 1.91M | 1.91M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.35M | 1.35M | 1.35M | 1.35M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.26M | 3.26M | 3.26M | 3.26M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.00K | 294.00K | 255.00K | 415.00K | -3.83M |